Bilix
Developer of PEGylated bilirubin nanoparticles designed to treat ischemia-reperfusion injury by reducing inflammation and oxidative stress. The company offers a nanoparticle-based therapy with demonst...
Valuation
$28.1M
Market implied
Share Price
N/A
Total Raised
$20K
Last Round
N/A